Rare diseases
Investigational molecules
Locations
Study of CFT1946 alone and with trametinib or cetuximab in patients with BRAF-V600 mutant solid tumors who have received standard treatment
FranceStudy on Hydroxycarbamide Resistance in Patients with Polycythemia Vera Identified by AI Predictors
GermanyStudy on PRAX-562 for Children with Developmental and Epileptic Encephalopathies
SpainStudy on the Safety and Effects of RBD1016 Injection for Patients with Chronic Hepatitis B on Nucleoside Analogues Treatment
SwedenStudy on Darolutamide and Androgen Deprivation Therapy for Men with Metastatic Hormone-Sensitive Prostate Cancer
LatviaStudy of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on Detecting Early Barrett's Esophagus Using Bevacizumab-800CW and Cetuximab-800CW for Patients with Barrett's Esophagus
The NetherlandsStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
AustriaContinued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies
BelgiumStudy on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis
AustriaStudy of BMS-986408 Alone or with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
